✦ LIBER ✦

Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting

✍ Scribed by Lu, Chien-Yu; Huang, Ching-Wen; Hu, Huang-Ming; Tsai, Hsiang-Lin; Huang, Chun-Ming; Yu, Fang-Jung; Huang, Ming-Yii; Chang, Se-Fen; Huang, Meng-Lin; Wang, Jaw-Yuan

Book ID: 122247544
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 455 KB
Volume: 164
Category: Article
ISSN: 1931-5244
DOI: 10.1016/j.trsl.2013.12.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

710: Clinical implication of UGT1A1 prom

710: Clinical implication of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab combined with FOLFIRI in the first-line setting

✍ Wang, J.; Lu, C.Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The genotyping of UGT1A1 polymorphism fo

The genotyping of UGT1A1 polymorphism for the dose adjustment of irinotecan in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab as the first-line regimen

✍ Lu, Chien-Yu; Tsai, Hsiang-Lin; Wang, Jaw-Yuan 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 169 KB

UGT1A1 genotyping for irinotecan-based c

UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases

✍ Yeh, Yung-Sung; Wu, Ming-Xia; Huang, Meng-Lin; Chang, Se-Fen; Chen, Chin-Fan; Hu 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 185 KB